10. Different groups Flashcards
How is ADME altered in a neonate?
A:
Enteral = lower gastric pH and slower gastric emptying and intestinal transit time = slower rate but increased proportion
Rectal = variable blood supply, so absorption placement dependent
Transdermal= thin stratum corneum = rapid
D: higher TBW, lower fat and increased BBB permeability. Decreased protein binding.
M: immature enzymes = reduced phase 1 (normal by first few years and slows again in puberty). Phase 2 varies.
E: lower egfr
How is ADME altered in the elderly?
A: slower gastric emptying (insignificant)
D: smaller TBW and higher body fat ratio. Decreased albumin and decreased muscle bulk (reduction in muscle blood flow making remi etc. longer to metabolise).
M: reduced hepatic blood flow and enzyme activity = lower first pass metabolism.
E: decreased EGFR and tubular secretion
How is ADME altered in pregnancy?
A: delayed gastric emptying =increased stomach uptake and reduced intestinal
D: increased TBW and fat. Dilution of albumin concentration and increased fatty acids compete for protein binding increasing free drug (alkaline still bing to alpha glycoprotein, so unchanged).
M: increased CO, hepatic blood flow and enterohepatic blood circulation. placental enzymes metabolise various neurotransmitters and drugs e.g. placental lactogen degrades insulin.
E: same
How does obesity alter ADME?
A: no significant change
D: increased body fat = difficult calculations, larger organs, increased blood volume
M: increased phase 2
E: difficult to calculate
What is ideal body weight?
How do we calculate it?
Estimate of lean body mass.
Men = height in cm - 100 and women = - 105.
How do we calculate lean body mass?
Male = (1.1 x weight) - (128 x (weight/height squared))
Female = (1.07 x weight) - (148 x (weight/height squared))
What are the names of the two formulae to calculate body surface area?
Dubois and mosteller
How is ADME altered in the critically ill?
IV preferred due to decreased BA.
A: blood diverted to vital organs away from gut, intestinal atrophy following starvation, reduced motility from hypoperfusion and opioids.
D: ph changes, fluid shifts to increase interstitial and reduced proteins.
M: hepatic flow increases in early sepsis and then reduces (reduces HER > 0.7 as dependent on CO). Low HER dependent on enzyme activity which is decreased by cytokines and acute phase proteins. Enteral feeding increases enzyme activity.
E: renal dysfunction
What is splicing and alternative splicing for mRNA?
Splicing: Pre-mRNA formed from introns and exons. Introns spliced out and exons form mRNA.
Alternative splicing: genes have different promoter regions which can cause different formation of exons being spliced from the same gene.
What are pharacogenomics and pharmacogenetics?
Genome = study of how whole genome alters drug response
Genetics = 1 gene alters response
What will result from SNP substitution?
Deletion?
Additions?
SNP = same amino acid from different codon, different amino acid or stop codon made.
Deletions and additions cause frameshift mutations.
What is the mutation in sux apnoea?
What are the different alleles involved?
Autosomal recessive Pseudocholinesterase mutation
Heterozygous = mildly prolonged
EU = normal
EA = atypical
Ef = fluoride resistant
Es = silent
Ea Ea = most common
Es Es = longest duration
How do we test for abnormal pseudocholinesterase genes?
Benzoylcholine is mixed with plasma cholinesterase producing a light emitting reaction.
Dibucaine (LA) binds to PCs reducing reaction
Abnormal genes reduce light
EuEu = 80% light inhibited = dibucaine number of 80
EaEa = DN of 20
Fluoride can also inhibit reaction and detects Ef gene.
No inhibition occurs in EsEs
What gene is responsible for codeine and tramadol metabolism?
What are the products?
What are the different issues with mutations of this?
CYP2D6
C = morphine
T = o methyl metabolite (1000x more potent at u receptors)
Get ultrafast metabolisers
Expected
Poor e.g. codeine resistant
What gene mutations can affect clopidogrel and what actions should we take?
Clopidogrel is a prodrug which is metabolised to active by CYP2C19
Ultrafast and extensive metabolisers = normal dose
Intermediate and poor need an alternative antiplatelet.